Ocular Tolerance, Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1.0, 1.5% in 48 Healthy Volunteers
Status:
Completed
Trial end date:
2002-04-01
Target enrollment:
Participant gender:
Summary
To compare the ocular tolerance, the safety and the ocular pharmacokinetics of 3
concentrations (0.5% - 1.0% - 1.5%) and the vehicle of T1225 after one drop instillation